Jergensen Joshua sold $1.8M of PACS

Jergensen Joshua (President & COO) sold 40,000 shares of PACS Group, Inc. (PACS) at an average of $45.59 ($44.53–$45.70, $1.82M total) across 2 trades on 2026-08-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Jergensen Joshua
Published Aug 14, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 9:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PACS
Neutral
medium confidence
Mentioned
$PACS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PACSNeutralLow
01

Why it matters

Traders may monitor insider activity as a sentiment input, but 10b5-1 sales are generally less informative than unscheduled sales.

02

Market read

A $1.82M insider sale by a top executive at PACS was newly disclosed, but the 10b5-1 structure suggests limited fundamental signal.

03

What to watch

The filing does not disclose reasons for the sale, and the net holdings after the sale remain large, limiting inference about long-term conviction.

Relevance 5/10Novelty 5/10Timing: Filed after-hours on 2026-08-14, reflecting sales executed on 2026-08-12.

Background

This is an SEC Form 4 insider transaction disclosure for PACS Group, Inc., reported by an officer (President and COO).

Company-level read

Ticker impact

$PACSNeutralMedium confidence
Context

PACS Group disclosed an insider open-market sale by President and COO Joshua Jergensen totaling about $1.82M under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact is likely short-lived and sentiment-driven.

Evidence & confidence

The transaction is an open-market sale executed under a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

No clear sector read-through from a single insider sale at PACS.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • PACS Group, Inc.

    Company whose insider transaction was disclosed on SEC Form 4.

  • Joshua Jergensen

    President and COO who sold shares in an open-market transaction under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PACSMedAI 8/10

What PACS Group (PACS) Said on Its Q3 Earnings Call

PACS Group reported 196 mature, 90 ramping, and 35 new skilled nursing facilities with occupancy ranging from 76.2% to 93.1%. The company acquired 32 Florida and 10 Texas skilled nursing operations post-quarter. PACS raised its 2026 revenue outlook to $5.95B-$6.05B and adjusted EBITDA to $685M-$695M, citing strength in existing operations and new acquisitions. Operating cash flow was $583.1M for the first nine months of 2026, with $707.4M in available liquidity.

$PACSHighAI 8/10

PACS Group Inc (PACS) (Q3 2026) Earnings Call Highlights: Revenue Tops

PACS Group Inc (NYSE:PACS) reported Q3 2026 revenue growth of 6.4%, with adjusted EBITDA up 33.6% to $175.7M. The company raised full-year guidance, citing strong occupancy and skilled mix improvements. PACS also highlighted a robust acquisition pipeline and integration plans for 31 Eduro facilities. Challenges include lower metrics at newly acquired facilities and ongoing government investigations.

$PACSHigh

Why is PACS stock surging today?

PACS Group Inc (PACS) stock rose 6.0% in after-hours trading after beating Q3 2026 earnings and revenue estimates. The company also raised its full-year 2026 Adjusted EBITDA and revenue guidance. Analysts maintain a 'Moderate Buy' rating with an average price target of $58.80. The surge was driven by company-specific news.